Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001713070-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | May 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
27,549
Total Value
$144,188.80
P&L
+inf% (+$742,485.22)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 14, 2026 | Grant/Award | 7,751 | $0.00 | $0.00 | 33,691 | Direct | โ | View Details | |
Director | Common Stock | โ | May 18, 2026 | Sale | 5,740 | $25.12 | $144,188.80 | 27,951 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | May 14, 2026 | Grant/Award | 14,058 | $0.00 | $0.00 | 14,058 | Direct | โ | View Details |